Stockreport

Cullinan Oncology to Participate in Upcoming Investor Conferences

Cullinan Therapeutics, Inc.  (CGEM) 
PDF CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan Oncology”) a biopharmaceutical company focused on modality-agnost [Read more]